Prevention of Acute Kidney Injury.
Acute kidney injury (AKI)
Cardiac surgery
KDIGO bundles
Prevention of acute kidney injury (AKI)
Renal biomarkers
Journal
Critical care clinics
ISSN: 1557-8232
Titre abrégé: Crit Care Clin
Pays: United States
ID NLM: 8507720
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
entrez:
7
9
2020
pubmed:
8
9
2020
medline:
11
8
2021
Statut:
ppublish
Résumé
Cardiac surgery-associated acute kidney injury (CSA-AKI) is a common complication after cardiac surgery and associated with a worse outcome. The pathogenesis of CSA-AKI is complex and multifactorial. Therapeutic options for severe CSA-AKI are limited to renal replacement therapy constituting a supportive measure. Therefore, risk identification, prevention, and early diagnosis are of utmost importance to improve patient outcomes. This review aims to provide an overview of the diagnosis, pathophysiologic mechanisms, and risk factors of CSA-AKI and delineates the strategies for AKI prevention available to improve patient outcomes after cardiac surgery.
Identifiants
pubmed: 32892822
pii: S0749-0704(20)30044-0
doi: 10.1016/j.ccc.2020.07.002
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
691-704Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure M. Küllmar and N-M. Wagner declare no conflicts of interest. A. Zarbock received fees from Astute Medical, BioMerieux, Braun, Baxter, Fresenius, AM Pharma, Amomed, AM Pharma, Ratiopharm, and Astellas and funding from Astute Medical, Astellas, Fresenius, Baxter, German Research Foundation, GIF, and BMBF. D. Engelman consults for Edwards Lifesciences.